Trial intelligence / Profile preview

Bupivacaine vs Ketorolac for Post-ICBG Pain

NCT00405262Phase 3Completed

Sponsor
SickKids
Start
May 2006
Primary completion
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by SickKids. Started May 2006; status: completed.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00405262.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00405262.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call